Genotoxicity, acute oral and dermal toxicity, eye and dermal irritation and corrosion and skin sensitisation evaluation of silver nanoparticles

References

• Ahamed M, Alsalhi MS, Siddiqui MK. 2010. Silver nanoparticle applications and human health. Clin Chim Acta 411:1841–1848.
   PubMed Web of Science ®Google Scholar
• Asharani PV, Hande MP, Valiyaveettil S. 2009. Anti-proliferative activity of silver nanoparticles. BMC Cell Biol 10:65.
   PubMed Web of Science ®Google Scholar
• Asharani PV, LianWu Y, Gong Z, Valiyaveettil S. 2008. Toxicity of silver nanoparticles in zebrafish models. Nanotechnology 19:255102.
   PubMed Web of Science ®Google Scholar
• Brandt D, Park B, Hoang M, Jacobe HT. 2005. Argyria: secondary to ingestion of homemade silver solution. J Am Acad Dermatol 53:S105–S107.
   PubMed Web of Science ®Google Scholar
• Burd A, Kwok CH, Hung SC, Chan HS, Gu H, Lam WK, 2007. A comparative study of the cytotoxicity of silver-based dressings in monolayer cell, tissue explant, and animal models. Wound Repair Regen 15:94–104.
   PubMed Web of Science ®Google Scholar
• Fung MC, Bowen DL. 1996. Silver products for medical indications: risk-benefit assessment. J Toxicol Clin Toxicol 24:119–126.
   Google Scholar
• Gerber C, Lang HP. 2006. How the doors to the nano-world were opened. Nat Nanotechnol 1:3–5.
   PubMed Web of Science ®Google Scholar
• Gulbranson SH, Hud JA Jr, Hansen RC. 2000. Argyria following the use of dietary supplements containing colloidal silver protein. Cutis 66:373–376.
   PubMed Web of Science ®Google Scholar
• Hussain SM, Hess KL, Gearhart JM, Geiss KT, Schlager JJ. 2005. In vitro toxicity of nanoparticles in BRL 3A rat liver cells. Toxicol In Vitro 19:975–983.
   PubMed Web of Science ®Google Scholar
• Johnston HJ, Hutchison GR, Christensen FM, Peters S, Hankin S, Aschberger K, 2010. A review of the in vivo and in vitro toxicity of silver and gold particulates: particle attributes and biological mechanisms responsible for the observed toxicity. Crit Rev Toxicol 40:328–346.
   PubMed Web of Science ®Google Scholar
• Kim S, Choi JE, Choi J, Chung KH, Park K, Yi J, 2009. Oxidative stress-dependent toxicity of silver nanoparticles in human hepatoma cells. Toxicol In Vitro 23:1076–1084.
   PubMed Web of Science ®Google Scholar
• Kim YS, Kim JS, Cho HS, Rha DS, Kim JM, Park JD, 2008. Twenty-eight-day oral toxicity, genotoxicity, and gender-related tissue distribution of silver nanoparticles in Sprague-Dawley rats. Inhal Toxicol 20(6):575–583.
   PubMed Web of Science ®Google Scholar
• Kim YS, Song MY, Park JD, Song KS, Ryu HR, Chung YH, 2010. Subchronic oral toxicity of silver nanoparticles. Part Fibre Toxicol 7:20.
   PubMed Web of Science ®Google Scholar
• KISTI Nano Weekly 210. 2006. The present status of Korean nanotechnology industrialization. Seoul: KISTI.
   Google Scholar
• Lee SM, Lee SH. 1994. Generalized argyria after habitual use of AgNO3. J. Dermatol 21:50–53.
   PubMedGoogle Scholar
• Magnuson B, Kligman AM. 1969. The identification of contact allergens by animal assay. The guinea pig maximization test. J Invest Dermatol 52:568–576.
   Web of Science ®Google Scholar
• Maneewattanapinyo P, Banlunara W, Thammacharoen C, Ekgasit S, Kaewamatawong T. 2011. An evaluation of acute toxicity of colloidal silver nanoparticles. J Vet Med Sci 73(11): 1417–1423.
   PubMed Web of Science ®Google Scholar
• Maron DM, Ames BN. 1983. Reviewed methods for the salmonella mutagenicity test. Mutat Res 113:173–215.
   PubMed Web of Science ®Google Scholar
• Marshall JP, Schneider RP. 1977. Systemic argyria secondary to topical silver nitrate. Arch Dermatol 113:1077–1079.
   PubMed Web of Science ®Google Scholar
• Maynard AD. 2006. Nanotechnology: a research strategy for addressing risk. Washington DC: Woodrow Wilson International Center for Scholars.
   Google Scholar
• Menaguale G, Fazio R, Fazio M. 2003. Argyria a case following the prolonged use of a rhinologic drug. Esper Dermatol (Roma) 4:299–303.
   Google Scholar
• Naddy RB, Gorsuch JW, Rehner AB, McNerney G.R, Bell RA, Kramer JR. 2007. Chronic toxicity of silver nitrate to Ceriodaphnia dubia and Daphnia magna, and potential mitigating factors. Aqua Toxicol 84:1–10.
   PubMed Web of Science ®Google Scholar
• OECD Guideline 402. 1987. OECD Guidelines for testing of chemicals: acute dermal toxicity. Paris: OECD.
   Google Scholar
• OECD Guideline 404. 2002. OECD Guidelines for testing of chemicals: acute dermal irritation/corrosion. Paris, France.
   Google Scholar
• OECD Guideline 405. 2002. OECD Guidelines for testing of chemicals: acute eye irritation/corrosion. Paris, France: OECD.
   Google Scholar
• OECD Guideline 406. 1992. OECD Guidelines for testing of chemicals: skin sensitisation. Paris, France.
   Google Scholar
• OECD Guideline 423. 2001. OECD Guidelines for testing of chemicals: acute toxic class method. Paris: OECD.
   Google Scholar
• OECD Guideline 471. 1997. OECD Guidelines for testing of chemicals: bacterial reverse mutation test. Paris: OECD.
   Google Scholar
• OECD Guideline 473. 1997. OECD guidelines for testing of chemicals: In vitro mammalian chromosome aberration test. Paris: OECD.
   Google Scholar
• Padlewska K, Schwartz R, Argyria In Kchan S, Vinson RP, Miller JJ, Gelfand James WD, 2007. In: Gross PR, editor. eMedicine: Dermatology and Online Medical Reference 2007. Omaha, NE: eMedicine.com, Inc. http://www.emedicine.com/.
   Google Scholar
• Park EJ, Yi J, Kim Y, Choi K, Park K. 2010. Silver nanoparticles induce cytotoxicity by a Trojan-horse type mechanism. Toxicol in Vitro 24:872–878.
   PubMed Web of Science ®Google Scholar
• Piao MJ, Kang KA, Lee IK, Kim HS, Kim S, Choi JY, 2011. Silver nanoparticles induce oxidative cell damage in human liver cells through inhibition of reduced glutathione and induction of mitochondria-involved apoptosis. Toxicol Lett 201:92–100.
   PubMed Web of Science ®Google Scholar
• Porter D, Sriram K, Wolfarth M, Jefferson A, Schwegler-Berry D, Andrew ME, 2008. A biocompatible medium for nanoparticle dispersion. Nanotoxicol 2(3):144–154.
   Web of Science ®Google Scholar
• Prescott RJ, Wells S. 1994. Systemic argyria. J Clin Pathol 47:556–557.
   PubMed Web of Science ®Google Scholar
• Samberg ME, Oldenburg SJ, Monteiro-Riviere NA. 2010. Evaluation of silver nanoparticle toxicity in skin in vivo and keratinocytes in vitro. Environ Health Perspect 118(3):407–413.
   PubMed Web of Science ®Google Scholar
• Wadhera A, Fung M. 2005. Systemic argyria associated with ingestion of colloidal silver. Dermatol Online J 11(1):12.
   PubMedGoogle Scholar
• Warheit DB, Donner EM. 2010. Rationale of genotoxicity testing of nanomaterials: regulatory requirements and appropriateness of available OECD test guidelines. Nanotoxicology 4:409–413.
   PubMed Web of Science ®Google Scholar
• Wijnhoven SWP, Peijnenburg WJG.M, Herberts CA, Hagens WI, Oomen AG, Heugens EHW, 2009. Nano-silver: a review of available data and knowledge gaps in human and environmental risk assessment. Nanotoxicology 3:109–138.
   Web of Science ®Google Scholar
• Yoon KY, Hoon BJ, Park JH, Hwang J. 2007. Susceptibility constants of Escherichia coli and Bacillus subtilis to silver and copper nanoparticles. Sci Total Environ 373:572–575.
   PubMed Web of Science ®Google Scholar